OsoBio Reaffirms DCAT Partnership Through New Leadership Positions

OsoBio President Milton Boyer to serve as vice president of DCAT’s executive committee
Albuquerque, NM Dec 17, 2013 – OsoBio has reaffirmed its long-standing partnership with the Drug, Chemical and Associated Technologies Association (DCAT) by accepting new volunteer leadership positions within the organization.
OsoBio President Milton Boyer will serve as vice president of DCAT’s executive committee in 2014. And Bob Cashman, vice president of business development at OsoBio, will serve as chairman of DCAT’s scholarship funding committee.
“Members direct DCAT’s efforts and events, which not only differentiates DCAT within the drug and chemical industries, but also increases its value proposition for individual participating companies like OsoBio,” Boyer said. “I am honored that my industry peers chose me to serve in this capacity for DCAT and am excited about what the year holds in store for all member companies.”
Founded in 1890, DCAT is a premier business development association whose membership consists of companies that manufacture, distribute or provide services to pharmaceutical, chemical, and related industries. Attended by thousands each March, the organization’s DCAT Week® is one of the pharmaceutical industry’s largest and most important educational and networking meetings. This year, Hillary Rodham Clinton, former U.S. Secretary of State, will be the keynote speaker at DCAT Week’s annual dinner.
OSO BioPharmaceuticals Manufacturing, LLC, is a contract manufacturing organization (CMO) that specializes in delivering injectable sterile liquid, suspension and lyophilized biologic and pharmaceutical products to the pharmaceutical industry. Our company offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization.
In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category. The U.S. Drug Enforcement Administration (DEA) has granted OsoBio registrations for Schedule II-V controlled substances.
OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects. To learn more about our company and the value we offer clients, visit www.OsoBio.com.

Intralign recently received a highly sought-after “Innovative Technology” award from Novation, the leading health care supply chain expertise, analytics and contracting company.

Intralign Earns “Innovative Technology” Award from Novation
Phoenix, AZ Dec 12, 2013 – Intralign recently received a highly sought-after “Innovative Technology” award from Novation, the leading health care supply chain expertise, analytics and contracting company. Intralign earned the distinction for its Intra-Operative Support service, which enables hospitals and surgeons to provide better quality of care and increase surgical throughput by supplying highly skilled Surgical First Assists (SFAs) to the operating room.
As part of a very competitive review process, Intralign’s Intra-Operative Support service was thoroughly evaluated by hospital member-led councils and found to have an incremental benefit over other products that focus on improving patient care or reducing the risk of harm to patients and care givers. Intralign SFAs can help reduce surgery time by 30 percent and increase surgeon throughput by 42 percent, all without sacrificing quality of care.
The significant designation was awarded after Novation’s Innovative Technology Expo in October and is only provided once a year to a small portion of products that are already available on contract through Novation.

Penlon Excited to Meet New Partners at Arab Health

Penlon is excited to once again have a significant presence at Arab Health 2014 and is looking to grow its already well-established and successful worldwide dealer partnerships
Abingdon, UK Dec 2, 2013 — Penlon Ltd, the UK’s largest manufacturer of anaesthesia delivery systems, is excited to once again have a significant presence at Arab Health 2014 and is looking to grow its already well-established and successful worldwide dealer partnerships. F
Join us on the booth to trial the Penlon Prima 460 and Prima 450 Anaesthesia systems and find out how you can win a Limited Edition Diamond Jubilee coin as your own souvenir of Queen Elizabeth’s reign.
On display on both the Penlon stand and the theatre suite on the ABHI stand is the new Penlon Prima 460 Anaesthesia system as well as other equipment. Packed full of features, the Prima 460 is the flagship model from the new Prima 400 series range, incorporating cleverly configured options for worldwide territory registrations and distribution. Clinicians will appreciate the generous work space and choice of two or three station Selectatec® compatible backbar, aiding maximum flexibility, ease of use and comfort. The Prima 460 on display is equipped with the SP M5 patient monitor, the latest generation Penlon patient monitor offering the highest level of performance and flexibility for theatre applications.
Also displayed is the award winning, Penlon Sigma Delta vaporizer. Sigma Delta delivers accurate concentrations under varying conditions of flow rate and temperature, particularly at low flow, and is service free over the first 10 years in service.
Also featured is the Penlon Diamond Fibrelight Laryngoscope. Fully interchangeable and internationally compatible blade and handle, this laryngoscope system provides brighter light, premium quality and performance for life.
As you would expect from a company with over 70 years dedicated experience Penlon devices feature intuitive user interfaces that require minimal operator training, putting clinicians in control, enabling them to focus on what is most important – patient safety and wellbeing.